As there is a physiological decline of the IGF with aging91, the interaction between IGF pathways and vitamin D is likely to be stronger for premenopausal than for postmenopausal women, leading to greater risk reduction in premenopausal breast cancer73,92. Here, IGF1 is linked to neoplasm.